• Structural Basis of TRPM3 Regulation by Neurosteroids and Pr

  2026-07-08

  This study delineates the molecular mechanisms by which neurosteroids and the anticonvulsant primidone regulate the TRPM3 ion channel. High-resolution cryo-EM structures reveal the ligand binding sites and gating effects, clarifying TRPM3’s role in pain and neurodevelopmental disorders and informing future therapeutic strategies.

• Praeruptorin A as a Ferroptosis Inhibitor in Cardiotoxicity

  2026-07-07

  Explore Praeruptorin A, a potent angular pyranocoumarin compound, as a targeted ferroptosis inhibitor for mitigating doxorubicin-induced cardiomyopathy. This article delivers original insights into molecular mechanisms, translational assay design, and the latest evidence, setting it apart from standard protocol guides.

• Advanced Biophysical Characterization of LNPs for mRNA Deliv

  2026-07-07

  The reference study establishes a new benchmark in lipid nanoparticle (LNP) analysis by leveraging high-resolution, solution-based biophysical techniques to elucidate LNP heterogeneity, RNA loading, and structural features. These insights clarify critical structure–function relationships in LNPs, informing the rational design of next-generation mRNA delivery systems for therapeutic and research applications.

• Multianimal MRI Advances Tumor Monitoring in Pancreatic Mode

  2026-07-06

  Kempinska et al. present a multianimal MRI protocol enabling simultaneous, high-resolution imaging of pancreatic tumors in up to four genetically engineered mice. This method increases efficiency and cost-effectiveness for preclinical studies, supporting more robust evaluation of therapeutics like gemcitabine in clinically relevant pancreatic cancer models.

• Sulfachloropyridazine in Research: Mechanisms, Microbiome, a

  2026-07-06

  Explore how Sulfachloropyridazine, a potent sulfonamide antibacterial agent, shapes research in enzyme inhibition and microbiome modulation. This article offers unique protocol insights and practical considerations for microbiological studies.

• Senescent CAFs Drive Immunosuppression in Breast Cancer Prog

  2026-07-05

  This study reveals that a subset of senescent cancer-associated fibroblasts (senCAFs) actively suppresses immune cell function and promotes breast tumor growth. Targeting these senCAFs could unlock new therapeutic avenues for restraining breast cancer progression and recurrence.

• CDK4's Role in 4E-BP1 Phosphorylation and Cap-Dependent Tran

  2026-07-04

  This article reviews the discovery that cyclin-dependent kinase 4 (CDK4) directly phosphorylates the translational repressor 4E-BP1, thereby promoting cap-dependent translation during the mitosis–G1 cell cycle transition. The findings reveal a cooperative mechanism between CDK4 and mTORC1, with implications for understanding drug resistance and cell proliferation in cancer biology.

• AZD3463 ALK/IGF1R Inhibitor: Advanced Workflows for Neurobla

  2026-07-03

  AZD3463, a potent ALK/IGF1R inhibitor from APExBIO, empowers researchers to dissect ALK-driven neuroblastoma mechanisms and optimize combination strategies with chemotherapeutics. This guide details robust experimental protocols, troubleshooting strategies, and workflow enhancements to maximize translational impact.

• HDAC Inhibition Suppresses BRD4-NUT Oncogenic Activity in NU

  2026-07-03

  Shiota et al. conducted a high-throughput screen identifying diverse histone deacetylase (HDAC) inhibitors as potent repressors of aberrant NUT function in NUT carcinoma cells. Their findings provide mechanistic insight into chromatin-targeted therapy and position HDAC inhibition as a promising approach for this aggressive malignancy.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–Receptor Bindi

  2026-07-02

  The reference study uncovers that endogenous angiotensin peptides, including Angiotensin (1-7), can significantly enhance the binding of the SARS-CoV-2 spike protein to cellular receptors, particularly AXL. These findings provide new mechanistic insight into viral pathogenesis and highlight potential intervention points for COVID-19 research.

• Oligo (dT) 25 Beads: Protocols and QC for Eukaryotic mRNA Is

  2026-07-02

  Oligo (dT) 25 Beads address the need for rapid, high-yield isolation of polyadenylated mRNA from eukaryotic total RNA or tissue lysates. They are best employed when intact, high-purity mRNA is required for workflows such as RT-PCR, cDNA synthesis, or sequencing. These beads are not suitable for prokaryotic samples or for workflows where polyA selection is unnecessary.

• PBS Liposomes: Advanced Controls for Neuroimmune Assays

  2026-07-01

  Explore how PBS Liposomes serve as innovative, inert controls in neuroimmune and macrophage phagocytosis assays. This in-depth analysis integrates mechanistic insights and recent TRPM3 research, elevating your understanding of assay design and control selection.

• HyperScribe T7 High Yield RNA Synthesis Kit Plus: Empowering

  2026-07-01

  Unlock high-yield, customizable RNA synthesis for advanced research applications with the HyperScribe T7 High Yield RNA Synthesis Kit Plus. This platform accelerates mRNA intervention studies and translational workflows, with robust troubleshooting support and proven performance in demanding use-cases like FLCN mRNA rescue.

• Difloxacin HCl: Bridging Antimicrobial Testing and MDR Rever

  2026-06-30

  Explore how Difloxacin HCl, a quinolone antimicrobial antibiotic, redefines translational research by uniting robust antimicrobial susceptibility testing with pioneering multidrug resistance reversal. This thought-leadership article integrates mechanistic insights, validated protocols, and strategic guidance, elevating the discussion beyond standard product summaries. Drawing on recent advances in cell cycle checkpoint regulation, we examine the cross-domain impact and future directions for translational scientists.

• GSK126 EZH2 Inhibitor: Precision Epigenetic Reprogramming in

  2026-06-30

  Explore how the GSK126 EZH2 inhibitor enables targeted epigenetic reprogramming in cancer research. This article offers a unique experimental perspective on assay optimization, integrating insights from recent mechanistic discoveries and practical protocol parameters.

450 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page